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PULLQUOTES 
 
 
 
There are two ways by which a baby can come into this world: vaginally or by Cesarean delivery. Although 
the developmental paths that result in either vaginal or Cesarean birth are highly diverse and very similar at 
the same time, the actual indication of whether a pregnant woman has to undergo surgery is usually clear. In 
most cases, Cesarean deliveries are performed for obstetric, fetal or maternal indications, some of which are 
considered absolute. For example, if the placenta or its vessels obscure the cervix (complete placenta previa 
or vasa previa, respectively), vaginal delivery would be lethal to the mother and/or her newborn. What is 
less clear, however, is the child’s developmental path after delivery. In particular, there is much debate on 
whether Cesarean delivery increases the risk of several diseases later in life, and whether any of these 
diseases result from a lack of exposure to the mother’s vaginal microbiota during birth.  
 
Cesarean delivery is the most common abdominal surgery in the USA, accounting for more than 1 million 
operations annually. Four decades ago, 1 in 20 births occurred via Cesarean, now it is 1 in 3 to 1 in 4. The 
appropriate rate of Cesarean delivery is not easily determined, since it depends not only on multiple 
maternal, fetal and obstetrical comorbidities and risk factors, but also on whether the mother had a Cesarean 
delivery before. The relative safety of Cesarean delivery – if performed by a competent obstetrical surgeon 
in a hospital – is recognized by patients and their providers alike, and the attributable risk of morbidity and 
mortality for both mother and child is extremely low. However, Cesarean delivery as a procedure has come 
under increasing scrutiny in recent years, in part owing to its real or perceived risk of future disease or harm 
for both the child and the mother.  
 
On the maternal side, there is limited risk with the first Cesarean surgery. However, repeated surgeries in 
subsequent pregnancies may cause bowel and bladder trauma, surgical adhesions and scarring, uterine scar 
separation, and adherent placentation such as placenta accreta or percreta with a high risk of accompanying 
massive blood transfusions and surgical complications. These hazards are relatively rare but highly morbid, 
and have inspired various approaches to reduce the rate of Cesarean deliveries, in particular primary 
surgeries.  
 
What has been less appreciated is the potential harm to the fetus, but such concerns have garnered 
considerable attention in recent years. Immediate threats for the baby include delayed delivery, owing to 
surgical adhesions or malpresentation, but these hazards are easily identified. In addition, there is emerging 
evidence that suggests an association between Cesarean delivery with increased rates of atopic allergic 
disorder and IgE-mediated sensitization to food allergens, as well as metabolic syndrome and obesity later in 
life. For instance, a recent large perspective study conducted over 16 years with more than 22,000 
participants found that Cesarean-delivered infants had a 13% increased risk of obesity later in life [1]. 
However, how much of that risk can be truly attributed to the Cesarean procedure itself (rather than what led 
to the Cesarean, or the company it keeps) remains unclear. Investigators studying the human microbiome 
have attributed these observations to a lack of exposure to the mother’s vaginal microbiota  – or conversely 
overt exposure to skin microbiota – during delivery. But is that attribution supported by the available 
evidence? And how strong is the causal link between Cesarean delivery per se and subsequent atopy or 
obesity in the child? 
 
Understanding the validity and robustness of these observations and identifying alternative risk factors, is 
very important. Wrongly attributing an outcome to an incorrect cause will affect potentially beneficial or 
efficacious interventions. If the maternal medical indication for the Cesarean rather than the surgical 
procedure itself increases health risks for the child, than earlier interventions to reduce the maternal 
indication and thereby the prevalence of Cesarean delivery would be both necessary and sufficient for 
preventing health risks for the child. For example, if maternal diet is overly rich in calories, which both 
disturbs the establishment of the infant’s microbiome and renders a large baby that cannot readily nor safely 
fit through the birth canal, then any helpful mediations would need to address her diet. Conversely, if it is a 
postnatal event that happens to co-associate with Cesarean delivery, then the mode of delivery becomes 
irrelevant and effective modifiers would be needed after birth. Such postnatal factors would, for instance, 
include breast milk versus formula feeding: obese women, who coincidentally have higher rates of Cesarean 
delivery, are more likely to feed formula. Hence, it is vitally important to understand whether it is the 
surgery, its indication or postnatal factors that may be behind reported links between Cesarean delivery and 
infant atopic diseases or obesity risks later in life. 
 
So, what do we know from the available literature about the association of Cesarean delivery on the gut 
microbiota and conversely on disease risk? Unfortunately, most studies to date do not report the indication 
for performing Cesarean delivery in the first place. In the landmark work by Dominguez-Bellow and co-
workers, the authors describe differences in the neonatal microbiome immediately after birth, and conclude 
that Cesarean delivery alters the early colonizers of the infant gut by denying initial exposure to the vaginal 
flora [2]. It should be noted that their analysis is based on samples within 5 minutes of delivery and the 
baby’s first stool collected within 24 hours. The differences therefore largely describe the microbes 
transmitted from the mother and not true colonization per se.  
 
Careful review of this study population also reveals other noteworthy details. The study enrolled 9 Mestizo 
and Amerindian women in Venezuela at the time of delivery and their 10 neonates. Four women and their 4 
infants make up the vaginal cohort; 5 women and 6 neonates represent the Cesarean cohort. Of these five 
women, one underwent surgery to deliver male twins. Except for the twins, the exact weight of each neonate 
was not given; the methods section of the manuscript states that “[a]ll mothers had healthy pregnancies and 
all babies were born at term, without complications. Babies weighed between 2 and 5.2 kg (the smallest 
baby was the twin in second order of birth, after his 3-kg brother)”. However, this would suggest that a 
minimum of two of pregnancies – presumptively both Cesarean – would not have met standard definitions 
of “healthy and uncomplicated”. First, the twins – chorionicity was not provided and both were male, so 
mono- versus di-zygosity (in other words, identical versus fraternal twins) may not be known – were 33% 
discordant in growth with reported weights of 2.0 and 3.0 kg. Discordance in twins is defined as the 
difference in birth weight between twins divided by the larger twin’s birth weight. A discordance of more 
than 20% is associated with adverse perinatal and postnatal outcomes.  
 
Second, at least one neonate was impressively larger than would be expected. This is called macrosomia, 
which is defined as a birth weight of more than 4 kg. In the USA, Cesarean is typically offered to diabetic 
mothers with a fetus estimated larger than 4.5 kg and a non-diabetic mother with a fetus estimated larger 
than 5 kg. A 5.2 kg fetus would be 0.8 to 1 kg heavier than more than 98% of the birth population according 
to WHO standards for male and female newborns, respectively (http://www.cdc.gov/growthcharts/). There 
are multiple underlying causes of fetal macrosomia, but the most common one is poorly controlled maternal 
diabetes. Additional causes include genetic and epigenetic overgrowth disorders, chronic caloric excess, and 
maternal obesity. Unfortunately, this small but highly cited landmark study did not provide the underlying 
indication for the Cesarean deliveries, but at least 3 cases raise concerns about potential metabolic or fetal 
growth abnormalities as evident by the authors’ brief description.  
 
Subsequent studies have further explored the impact of potential confounders in greater depth, though they 
still remain underreported (see Further Reading). For instance, a Canadian study of mothers and their infants 
categorized Cesarean deliveries as either being elective or emergent, and found differences in bacterial 
richness and diversity. However, truly elective Cesarean deliveries and truly emergent Cesarean deliveries 
are extremely rare, and may not reflect the varying degrees of time that a fetus may be exposed to the 
vaginal canal. Further confounders that are scarcely accounted for in the literature include maternal 
intrapartum and neonatal antibiotic exposure, gestational age, diet, host genetics and environment, amongst 
others. For instance, vaginal and placental microbiomes vary by gestational age throughout pregnancy, thus 
infants delivered preterm have different in utero and intrapartum exposure. Maternal intrapartum antibiotics 
and infant diet have also been shown to significantly alter the infant microbiome, with reduced bacterial 
diversity most prominent in breastmilk-fed infants whose mothers received intrapartum antibiotics. 
However, all subjects in this study were delivered by vaginal delivery, thus the influence of birth mode was 
not explored. Another study demonstrated that intrapartum antibiotics and Cesarean delivery significantly 
altered the neonatal gut microbiome, which was somewhat mitigated by breastmilk feeding. Furthermore, 
intrapartum antibiotics and preterm birth result in significant alterations to the microbiome and inferred 
metabolic function, with significantly lower levels of health-associated short-chain fatty acids (SCFAs) and 
altered antibiotic resistance profiles. With so many variables known to perturb the developing microbiome, 
these latter studies demonstrate the importance of capturing multiple variables in microbiome analyses and 
not just attributing alterations to whether the infant passed through the vaginal canal. 
 
Is there evidence of other potential factors that alter the microbiome, and that are associated with a higher 
occurrence of Cesarean surgery? Perhaps the best-studied possible cause to date is maternal high-fat diet and 
obesity. The notion that weight gain, high-fat diet and microbiome composition are intertwined is now well 
established, with excellent examples of causality in murine models. Transferring the gut microbiome from 
obese mice to germ-free mice promotes adiposity and other studies showed that bacterial functioning is 
strongly influenced by a high-fat diet. We have used a primate model and shown that maternal diet infers 
significant and persistent alterations to the juvenile microbiome, even when juveniles are co-housed and 
switched back to a healthful diet after weaning [3]. More recently, we confirmed these findings in a large 
human cohort of mothers and their infants, which showed that a maternal high-fat diet is associated with 
alterations in the infant microbiome at birth, and that these changes persist for at least 4 to 6 weeks after 
birth [4]. Notably, this time frame encompasses the vast majority of studies that explore the role of birth 
mode on the developing gut microbiome in infants. 
 
Given the lack of clear evidence that Cesarean delivery poses a health risk for newborns by way of changes 
in the gut microbiota, what is the evidence that mode of delivery actually impacts on the baby’s microbiota? 
In other words, are there microbial species or genera that are uniformly present in all vaginally delivered 
infants, and uniformly absent in all Cesarean-born babies? A recent study of 39 Finnish infants, based on 
monthly samples from month 2 to year 3 of life, showed that 20% of vaginally delivered infants more 
closely resembled Cesarean-delivered infants in terms of the composition of their gut microbiome [5]. This 
was attributed to a low profile of Bacteroides species, which was not associated with any relevant clinical 
variables, such as maternal intrapartum antibiotics, gestational age, duration of delivery, time in hospital, 
and so on.  
 
Previous studies had suggested that prolonged effects of birth mode on microbiota composition that co-
occurred with Cesarean delivery results in reduced bacterial diversity throughout the initial years of life. 
However, Yassour and co-workers importantly demonstrate that this effect results from the low-Bacteroides 
group, which was independent of delivery mode [5]. It was also notable that infants from the 16S-taxonomic 
profiled low-Bacteroides group – Cesarean birth and 20% of vaginally delivered infants – generally had 
higher abundances of Bifidobacteria. In accordance with this Finnish study, a separate study exploring the 
microbiome development in 43 American infants during the first 2 years of life showed reduced Bacteroides 
abundances in Cesarean-delivered infants [6]. Although the US study did not specifically explore the low-
Bacteroides profiles, as reported by Yassour et al. to occur in 20% of vaginal deliveries, they found no 
difference in the abundance of Bacteroides among Cesarean and vaginally delivered infants after one year.  
 
Because Bacteroides species have been demonstrated to positively influence the immune system in animal 
models, it has been widely speculated that a low-Bacteroides profile associated with Cesarean delivery 
potentially puts the infant at risk for future disease. This may not be a correct assumption, however. For 
example, in addition to Cesarean delivery, a 16S-assigned low Bacteroides profile is also associated with 
exclusive breast milk feeding. Clearly, exclusive breast milk feeding is uniformly recommended and has 
tremendous long-term health benefits and no known harms. Conversely, maternal high-fat diet and maternal 
obesity are also associated with both Cesarean delivery and lower Bacteroides profiles. Disentangling 
correlation and causation between such co-linear variables ultimately requires additional studies in relevant 
models. However, few studies to date have explored how a Cesarean birth-associated microbial profile in 
humans directly leads to alterations of host biology that eventually manifests as disease. In fact, in one of the 
few studies that sought to establish such as causal link, namely alterations to the regulatory component of 
the immune system associated with Cesarean delivery, the immune modulating affect was attributed to 
higher proportions of Bacteroides [7]. However, despite these changes, it reported no overt phenotype in 
adult mice. Certainly, additional work in experimental models is needed to further establish if such a causal 
mechanism exists, but considering the multitude of factors that shape the early microbiome, demonstrating 
such a link may prove difficult.    
 
Along these lines, Dominguez-Bello and co-workers took an innovative and provocative approach to 
establish causation by “restoring” the infant microbiome of Cesarean-delivered infants with maternal 
vaginal flora [8]. Through incubating a gauze in the mothers vagina for 1 hour before surgery and 
subsequently ‘wiping’ the neonates mouth, face and body at the time of delivery, the team described that 
they were able to “partially restore” bacterial members from the vaginal flora into the neonate microbiome 
when measured over 30 days. Although the study size was appropriate for a pilot study – 18 women and 
their infants – only 4 of the total of 11 Cesarean-delivered infants were exposed to vaginal wiping. The 
authors report that, among Cesarean babies exposed to maternal vaginal fluids, the skin and oral sites were 
most comparable to vaginally delivered infants, whereas the anal site remained more comparable to 
Cesarean-delivered infants who did not undergo vaginal wiping. They conclude that Cesarean babies 
“lacked the vaginal bacteria that were restored by swabbing infants with gauze or that were present in 
vaginally delivered infants-particularly anal and skin Lactobacillus early in life”.  
 
However, close inspection of the relative abundance of bacterial taxa at these sites revealed that this 
conclusion is based on limited repeat sampling data from a variable and small number of infants. Of the 4 
Cesarean-delivered babies who were exposed to vaginal wipes, only one neonate yielded data at every time 
point. Similarly, of the 11 Cesarean-delivered neonates who did not undergo vaginal wiping, only two had 
anal and skin sample data and none had oral data from the initial day 1 reference time point. In fact, careful 
review of all body site samples reveal inconsistent sampling data among subjects at all six time points, 
making restorative analysis challenging.  
 
Nevertheless, the authors conclude that Lactobacillus dominates anal samples in 25% of vaginally-exposed 
infants at day 1 – comparing a pool of four neonates to a pool of two – while samples collected on day 3 are 
more comparable to Cesarean-delivered newborns who were not vaginally wiped by comparing a pool of 2 
neonates to a pool of 9 neonates. The authors comment that “In anal samples from exposed infants and 
vaginally delivered infants, there was an early enrichment of Lactobaccillus followed by a bloom of 
Bacteroides from week 2, which was not observed in newborns that were not exposed to vaginal fluids.” 
However, it is unclear how robust these observations are, since only a single Cesarean-delivered infant 
sampled at day 7 and 14 and the referenced relative abundance plots do not appear to display Bacteroides 
(Supplementary Figure 3). These observations may be further limited by the fact that the only exclusively 
breastmilk-fed infants were the 3 who were delivered vaginally, and all Cesarean-delivered infants in the 
study received at least some formula. Nonetheless, this proof-of-principal study suggests one innovative 
potential method of partially restoring microbiota in neonates. It remains to be seen whether these findings, 
if are replicated in future studies with consistent longitudinal sampling over a longer time interval, will have 
a meaningful long-term impact, or if efficacious interventions would need to be implemented long before 
the intrapartum interval and birth. 
 
Regardless of the potential efficacy of such interventions, it remains unclear if and how birth mode 
influences disease risk factors by modulating the microbiota, given that any initial differences in the infant 
microbiota between vaginal or Cesarean delivery become less profound or actually disappear over time. As 
noted by Bokulich et al., “we found that Cesarean- and vaginally delivered infants demonstrated similar 
degrees of microbiota maturation during the first 6 months of life. Subsequently, microbiota maturation 
stagnated in Cesarean-delivered infants, with relative maturation dropping compared to vaginally born 
infants for the remainder of the study period” [6]. However, this same study also noted considerable 
differences based on formula feeding and timing of the introduction of solid foods. Owing to the chaotic and 
stochastic development of the gut microbiota during the initial years of life, future studies need to implement 
large cohorts with robust longitudinal sampling and detailed consideration of potential prenatal, intrapartum 
at-birth, and postnatal confounders.  
 
Although parturition was traditionally assumed to be the first point at which neonates are exposed to 
bacteria, emerging evidence indicates that this may not be true. The presence of microbes and microbial 
communities within the intrauterine space – the placenta, amniotic fluid and meconium – has been 
consistently documented in healthy-term pregnancies, indicating that colonization of the fetal microbiome 
may occur in early gestation. However, how and from whence these microbiota arise is not yet fully 
understood. Nevertheless, these observations have tremendous implications for informing our understanding 
of the dynamics of the early microbiome in humans as it introduces the gestational period as a time during 
which the fetal microbiota may be initially established. As a result, exposures and events throughout 
pregnancy that may ultimately result in a Cesarean or follow thereafter – but not the surgery itself – may be 
the true drivers of variation in the microbiome and risk of atopic disease, obesity or metabolic disorders later 
in life.  
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Figure Legends 
 
Figure 1 | General Composition of the Maternal and Infant Microbiome in Pregnancy and Early Life. 
The composition of the microbiome is unique to each body niche. As demonstrated by the pie charts, the 
relative abundance of each major phyla are different between body sites, although considerable variation 
exists. Recent evidence has also demonstrated unique populations of bacteria in the intrauterine 
environment, including the placenta and amniotic fluid.  
 
Figure 2 | Important Modifying Factors Thought to Impact the Microbiome Throughout Life. The first 
contact with microbiota may begin during late gestation, with the largest exposure at the time of delivery. 
Over time, the abundance and diversity of the infant microbiome increases with life, stabilizes around the 
time that the infant begins to eat solid foods and persists throughout adulthood. A number of modifying 
factors are thought to have an influential role in shaping the identity and abundance of the infant microbiota 
throughout life. However, few studies have specifically examined major modifying factors within childhood 
and adolescence. 
 
